19591-7 |
6-Monoacetylmorphine |
ACnc |
Urine |
Pt |
Ord |
Screen |
|
DEPRECATED |
Deprecated 6-Monoacetylmorphine [Presence] in Urine by Screen method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19591-7 |
|
Screen |
|
|
|
|
|
|
0 |
Deprecated 6MAM Ur Ql Scn |
|
|
|
|
|
6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; Arbitrary Concentration; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin metabolite; Illicit; MAM; Ordinal; Point in time; PotentialForAbuse; Ql; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
19592-5 |
6-Monoacetylmorphine |
ACnc |
Urine |
Pt |
Ord |
Confirm |
|
DEPRECATED |
Deprecated 6-Monoacetylmorphine [Presence] in Urine by Confirm method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19592-5 |
|
Confirm |
|
|
|
|
|
|
0 |
Deprecated 6MAM Ur Ql Cfm |
|
|
|
|
|
6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; Arbitrary Concentration; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Heroin metabolite; Illicit; LC/MS/MS; MAM; Ordinal; Point in time; PotentialForAbuse; Ql; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
19593-3 |
6-Monoacetylmorphine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19593-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
6MAM Ur Cfm-mCnc |
|
|
|
Y |
|
6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Heroin metabolite; Illicit; LC/MS/MS; Level; MAM; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19594-1 |
6-Monoacetylmorphine |
MCnc |
Urine |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Monoacetylmorphine [Mass/volume] in Urine |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19594-1 |
|
|
|
|
|
|
|
|
0 |
Deprecated 6MAM Ur-mCnc |
|
|
|
Y |
|
6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin metabolite; Illicit; Level; MAM; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.4 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
19595-8 |
6-Monoacetylmorphine cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
DEPRECATED |
Deprecated 6-Monoacetylmorphine cutoff [Mass/volume] in Urine for Screen method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19595-8 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Deprecated 6MAM CtO Ur Scn-mCnc |
|
|
|
Y |
|
6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; CtO; DRUG/TOXICOLOGY; Drugs; Heroin metabolite; Level; MAM; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
19596-6 |
6-Monoacetylmorphine cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
DEPRECATED |
Deprecated 6-Monoacetylmorphine cutoff [Mass/volume] in Urine for Confirm method |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19596-6 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Deprecated 6MAM CtO Ur Cfm-mCnc |
|
|
|
Y |
|
6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Heroin metabolite; LC/MS/MS; Level; MAM; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
19597-4 |
Morphine |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Morphine [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19597-4 |
|
Screen |
|
|
Both |
|
|
|
0 |
Morphine Ur Ql Scn |
|
|
|
|
|
Addiction; c260; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Morphine sulfate; MS; MSO4; OMPH; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19599-0 |
Morphine cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Morphine cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19599-0 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Morphine CtO Ur Scn-mCnc |
|
|
|
Y |
|
c260; CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Morphine sulfate; MS; MSO4; OMPH; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
196-6 |
Cloxacillin |
Susc |
Isolate |
Pt |
Qn |
MLC |
|
ACTIVE |
Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
196-6 |
|
MLC |
|
|
Observation |
|
|
|
0 |
Cloxacillin Islt MLC |
|
|
|
Y |
|
Alclox; Ampiclox; Amplium; ANTIBIOTIC SUSCEPTIBILITIES; APO-CLOXI; AST; Austrastaph; Clocillin; Cloxin; Ekvacillin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Novo-cloxi; Nu-cloxi; Orbenin; Penstapho n; Point in time; QNT; Quan; Quant; Quantitative; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tegopen |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
1960-4 |
Bicarbonate |
SCnc |
BldA |
Pt |
Qn |
|
|
ACTIVE |
Bicarbonate [Moles/volume] in Arterial blood |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
1960-4 |
|
|
|
|
Both |
|
|
|
0 |
HCO3 BldA-sCnc |
|
|
|
Y |
|
ABG; ART; Art bld; Art blood; Arterial; Arterial blood; BIC; bicar; Bicarb; Blood arterial; Chemistry; HCO3; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration |
2.73 |
1 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
19600-6 |
Morphine cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Morphine cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19600-6 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Morphine CtO Ur Cfm-mCnc |
|
|
|
Y |
|
c260; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Morphine sulfate; MS; MSO4; OMPH; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19601-4 |
Morphine.free |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Morphine Free [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19601-4 |
|
Screen |
|
|
Both |
|
|
|
0 |
Morphine Free Ur Ql Scn |
|
|
|
|
|
c260; DRUG/TOXICOLOGY; Drugs; FR; Morphine Free; Morphine sulfate; MS; MSO4; Non-protein bound; OMPH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; unconjugated morphine; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19602-2 |
Morphine.free |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Morphine Free [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19602-2 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Morphine Free Ur Ql Cfm |
|
|
|
|
|
c260; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; FR; GCMS; LC/MS/MS; Morphine Free; Morphine sulfate; MS; MSO4; Non-protein bound; OMPH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; unconjugated morphine; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19603-0 |
Morphine.free cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Morphine Free cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19603-0 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Morphine Free CtO Ur Scn-mCnc |
|
|
|
Y |
|
c260; CtO; DRUG/TOXICOLOGY; Drugs; FR; Level; Mass concentration; Morphine Free; Morphine sulfate; MS; MSO4; Non-protein bound; OMPH; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; unconjugated morphine; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19604-8 |
Morphine.free cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Morphine Free cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19604-8 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Morphine Free CtO Ur Cfm-mCnc |
|
|
|
Y |
|
c260; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; FR; GCMS; LC/MS/MS; Level; Mass concentration; Morphine Free; Morphine sulfate; MS; MSO4; Non-protein bound; OMPH; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; unconjugated morphine; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19605-5 |
Nalbuphine |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Nalbuphine [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19605-5 |
|
Screen |
|
|
Both |
|
|
|
0 |
Nalbuphine Ur Ql Scn |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Nubain; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
19607-1 |
Nalbuphine cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Nalbuphine cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19607-1 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Nalbuphine CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nubain; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19608-9 |
Nalbuphine cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Nalbuphine cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19608-9 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Nalbuphine CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Nubain; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19609-7 |
Naltrexone |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Naltrexone [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19609-7 |
|
Screen |
|
|
Both |
|
|
|
0 |
Naltrexone Ur Ql Scn |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Revia; Scn; Scr; Screen; Scrn; UA; UR; Urn; Vivitrol |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
1961-2 |
Bicarbonate |
SCnc |
BldC |
Pt |
Qn |
|
|
ACTIVE |
Bicarbonate [Moles/volume] in Capillary blood |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
1961-2 |
|
|
|
|
Both |
|
|
|
0 |
HCO3 BldC-sCnc |
|
|
|
Y |
|
BIC; bicar; Bicarb; Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Finger stick; HCO3; Level; Lung; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Substance Concentration |
2.73 |
1 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
19610-5 |
Naltrexone |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Naltrexone [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19610-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Naltrexone Ur Cfm-mCnc |
|
|
|
Y |
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Revia; UA; UR; Urn; Vivitrol |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19611-3 |
Naltrexone |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Naltrexone [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19611-3 |
|
|
|
|
Both |
|
|
|
0 |
Naltrexone Ur-mCnc |
|
|
|
Y |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Revia; UA; UR; Urn; Vivitrol |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19612-1 |
Naltrexone cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Naltrexone cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19612-1 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Naltrexone CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Revia; Scn; Scr; Scrn; UA; UR; Urn; Vivitrol |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19613-9 |
Naltrexone cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Naltrexone cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19613-9 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Naltrexone CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Revia; UA; UR; Urn; Vivitrol |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
19614-7 |
N-desalkylflurazepam |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
N-desalkylflurazepam [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19614-7 |
|
Screen |
|
|
Both |
|
|
|
0 |
Desalkylfluraz Ur Ql Scn |
|
|
|
|
|
Desalkyfluraz; Desalkylfluraz; Desalkylflurazepam; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; norfludiazepam; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |